ADHD rule change 'not thought through sufficiently', GP warns
NZ Herald
A recent rule change allowing GPs and nurse practitioners to prescribe ADHD medication in New Zealand may not be adequately supported by training or assessment standards, according to a study published in the New Zealand Medical Journal. The researchers warn that without proper guidance and quality assurance, the expansion of prescribing rights may not effectively address long wait times for ADHD assessments or improve access to care. The article highlights concerns that the change was not sufficiently thought through and emphasizes the need for a standardized, agreed-upon pathway for ADHD assessment and treatment.
All articles from 25 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.